Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$9.39 USD
+0.04 (0.43%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $9.38 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Avid Bioservices, Inc. [CDMO]
Reports for Purchase
Showing records 21 - 40 ( 62 total )
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Growing Backlog and Expanding Biological Production Capacity
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Continued Execution in 2Q; Downgrading to Sector Weight on Valuation
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
A Move into Cell & Gene Therapy with Viral Vector Build Out
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Life Science Tools: Industry Tailwind of Record FDA Approvals Likely Growing Stronger
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Biological Manufacturing Expansion On-Track
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Inaugural KBCM Life Sciences & MedTech Forum: Day 2 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
An Impressive Earnings Beat Underpins Tight Biological Production Demand
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Company: Avid Bioservices, Inc.
Industry: Medical - Biomedical and Genetics
Increasing Biological Demand & Capex; Raising PT from $12 to $22
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department